CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 100 filers reported holding CHEMOCENTRYX INC in Q1 2018. The put-call ratio across all filers is 1.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $243,000 | -26.8% | 26,176 | +9.6% | 0.01% | -30.0% |
Q1 2019 | $332,000 | +395.5% | 23,876 | +111.3% | 0.02% | +566.7% |
Q4 2017 | $67,000 | -65.3% | 11,297 | -66.3% | 0.00% | -70.0% |
Q4 2013 | $193,000 | +62.2% | 33,501 | +55.8% | 0.01% | +66.7% |
Q3 2013 | $119,000 | -71.5% | 21,501 | -27.4% | 0.01% | -57.1% |
Q2 2013 | $418,000 | – | 29,602 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |